Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis

BACKGROUND AND AIM: A large number of studies have tried to combine sorafenib with TACE for patients with unresectable hepatocellular carcinoma (HCC) and the results were controversial. We conducted this systematic review and meta-analysis to evaluate the safety and efficacy of combination therapy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Chen, Hui, Wang, Mengmeng, Zhao, Yan, Cai, Guohong, Qi, Xingshun, Han, Guohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961236/
https://www.ncbi.nlm.nih.gov/pubmed/24651044
http://dx.doi.org/10.1371/journal.pone.0091124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961236/
https://www.ncbi.nlm.nih.gov/pubmed/24651044
http://dx.doi.org/10.1371/journal.pone.0091124

Ejemplares similares